Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Investor Letter Reveals John Burbank Beat the Market in September; Take a Look at His Top Picks

Page 1 of 2

John Burbank‘s Passport Capital managed to perform much better than many of its peers due to its short exposure. In its September letter to investors, Passport revealed a return of 2.8% for its Global Strategy in September and 18% gains on a year-to-date basis. This compares with losses of 3.6% and 2.5% registered by the MSCI AC World and the S&P 500, respectively, in September, in addition to their year-to-date declines of 6.6% and 5.3%, respectively. Passport Capital ended September with a net exposure of -16% with 78% short and 57% long. On the long side of its portfolio, five stocks ranked as the top contributors at the end of September and we are going to take a closer look at them in this article.


Why are we interested in the stocks in which John Burbank prefers to invest? The reason is simple, we believe that imitating investors like Burbank can help us identify profitable opportunities among the thousands of companies that are trading on the market. By identifying stocks that the 730+ funds from our database are collectively bullish on, we can beat the market by as much as over ten percentage points annually. The key is to focus on their most popular small-cap picks. Our strategy follows the 15 most popular small-caps among hedge funds and it has returned 102% since August 2012, beating the market by 53 percentage points (see more details here).

John Burbank
John Burbank
Passport Capital

Passport had exposure of 7% to CF Industries Holdings, Inc. (NYSE:CF) in its portfolio at the end of September, while in its most recent 13F filing (for the end of June), the fund revealed ownership of 4.18 million shares of the company. The stock lost 29% in the third quarter and plunged by 9% yesterday on the back of lower-than-expected financial results for the third quarter. CF Industries Holdings, Inc. (NYSE:CF) posted earnings of $0.39 per share, well below the $0.73 expected by analysts, on revenue of $927.4 million, above analyst estimates of $887 million. The sentiment for the stock among the investors from our database is also weak, with the number of funds bullish on CF Industries Holdings, Inc. (NYSE:CF) declining by 13 to 47 during the second quarter, while in aggregate these funds held 3% of the company’s outstanding stock.

Follow Cf Industries Holdings Inc. (NYSE:CF)
Trade (NYSE:CF) Now!

In utilities company Sempra Energy (NYSE:SRE), Passport did not disclose holding shares in its latest 13F filing, but in the letter, it revealed having 5% exposure to the company. In its latest earnings report, Sempra Energy (NYSE:SRE) reported EPS of $1.00, above the estimates of $0.88. The stock is down by 7% year-to-date and sports a dividend yield of 2.69%. Goldman Sachs put the stock on its ‘Conviction Buy’ list back in June with a $130 price target, and overall, most analysts rate the stock as a ‘Buy’. At the end of June, 33 funds among those that we track held 4% of Sempra Energy (NYSE:SRE)’s outstanding common stock.

Follow Sempra Energy (NYSE:SRE)
Trade (NYSE:SRE) Now!

The other top three holdings of Passport Capital are represented by SolarCity Corp (NASDAQ:SCTY), Vipshop Holdings Ltd – ADR (NYSE:VIPS), and NRG Energy Inc (NYSE:NRGand we are going to discuss them in more detail on the following page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!